- Home
- SPB vs TNGX Comparison
SPB vs TNGX Comparison
Compare SPB & TNGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SPB | TNGX |
|---|---|---|
| Founded | 1906 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Pharmaceutical Preparations |
| Sector | Miscellaneous | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.4B | 1.5B |
| IPO Year | 1994 | 2020 |
Fundamental Metrics
Financial Performance| Metric | SPB | TNGX |
|---|---|---|
| Price | $73.62 | $17.22 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 9 |
| Target Price | ★ $82.40 | $18.75 |
| AVG Volume (30 Days) | 320.7K | ★ 3.4M |
| Earning Date | 05-07-2026 | 06-01-2026 |
| Dividend Yield | ★ 2.53% | N/A |
| EPS Growth | N/A | ★ 26.89 |
| EPS | ★ 1.21 | N/A |
| Revenue | ★ $3,802,100,000.00 | $62,384,000.00 |
| Revenue This Year | $1.78 | N/A |
| Revenue Next Year | $1.85 | $13.81 |
| P/E Ratio | $61.36 | ★ N/A |
| Revenue Growth | 20.86 | ★ 48.29 |
| 52 Week Low | $49.99 | $1.04 |
| 52 Week High | $80.42 | $17.63 |
Technical Indicators
Market Signals| Indicator | SPB | TNGX |
|---|---|---|
| Relative Strength Index (RSI) | 45.41 | 72.25 |
| Support Level | $51.36 | $10.90 |
| Resistance Level | $80.42 | $17.63 |
| Average True Range (ATR) | 2.35 | 1.15 |
| MACD | -0.95 | 0.45 |
| Stochastic Oscillator | 3.36 | 95.02 |
Price Performance
Historical ComparisonAbout SPB Spectrum Brands Holdings Inc.
Spectrum Brands Holdings Inc is consumer products and home essentials company. The company is a supplier of consumer batteries, residential locksets, residential builders' hardware, grooming products and personal care products. The company manages the businesses in product-focused segments; Home and Personal Care, global Pet Care, and Home and Garden. The Company manufactures, markets and distributes its products globally in the North America, Europe, Middle East & Africa, Latin America, and Asia-Pacific.
About TNGX Tango Therapeutics Inc.
Tango Therapeutics Inc is a biotechnology company. It is dedicated to discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. It is engaged in the business of discovering and developing precision oncology therapies. It is currently developing two MTA-cooperative PRMT5 inhibitors; TNG462 for non-CNS cancers, including pancreatic and lung cancer, and TNG456, a next-generation, brain-penetrant PRMT5 inhibitor, for CNS cancers, including GBM. Its pipeline products are PRMT5 and CoREST.